Sanne Y Smith-Apeldoorn

6PUBLICATIONS
10CO-AUTHORS
Behavioural epidemiologySocial epidemiologyEpidemiological methodsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 31, 2026
Oral Esketamine Maintenance Treatment for Treatment-Resistant Depression: Clinical Outcomes During an Off-Label Treatment Program.

|May 28, 2025
Auto-Induction in Oral Esketamine Treatment for Treatment-Resistant Depression: An Exploratory Study.

|Apr 26, 2025
Oral esketamine for patients with severe treatment-resistant depression: Effectiveness, safety, and tolerability of a six-week open-label treatment program.

Jolien Ke Veraart, Sanne Y Smith-Apeldoorn, Annemarie van der Meij

|May 12, 2022
The antidepressant effect and safety of non-intranasal esketamine: A systematic review.

Sanne Y Smith-Apeldoorn, Maurice Vischjager, Jolien Ke Veraart

|Dec 06, 2021
Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study.

Sanne Y Smith-Apeldoorn, Jolien K E Veraart, Henricus G Ruhé

|Dec 01, 2019
Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial.

Sanne Y Smith-Apeldoorn, Jolien K E Veraart, Jeanine Kamphuis

Pageof 1

Frequent Collaborators

3 joint publications

Robert A Schoevers

3 joint publications

Jolien Ke Veraart

1 joint publications

Henricus G Ruhé

1 joint publications

Cornelis F Vos